TMS has been shown to be effective for the treatment of depression. We are trialing an investigational new form of transcranial magnetic stimulation (TMS) to study treatment-resistant depression.
If you are between the ages of 22 and 75 and have failed at least 2 anti-depressant medications, you may be eligible to participate in our study.
If you are interested to learn more or participate in screening, you can use the link below to fill out our screening questionnaires: https://is.gd/stanford_atbs_study
Additional information about our clinical trials is available on our lab website: http://med.stanford.edu/bsl/research.html
Participant's rights questions, contact 1-866-680-2906.